Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?

Figure 2

Unrooted cluster tree comparing the index tumor (Patient) to normal renal tissue (NO, ), chromophobe RCC (CHR , ), oncocytoma (ON, ), clear cell RCC (CC, ), papillary type 1 RCC (P1, ), papillary mixed type 1/type 2a RCC (P1.2A, ), papillary type 2a RCC (P2A, ), and papillary type 2b RCC (P2B, ) based on the 500 most variable genes.